Isolated Percutaneous Endoscopic Gastrostomy Site Malignancy Due To Nasopharynx Cancer: A Case Report

Year 2024, , 231 - 235, 30.06.2024

Yahya Kaan Karatepe , Salih Boluk , Sümeyra Emine Bölük , Çağrı Bilgiç , Mahmut Salih Genç

https://doi.org/10.52827/hititmedj.1393887

Abstract

PEG (Percutaneous Endoscopic Gastrostomy) procedure is a method used in patients with head and neck cancers whose oral intake is impaired. Although very rare, metastasis may occur due to the possible implantation of tumor cells compatible with primary malignancy at the PEG site. In our case report, we aimed to present a patient who was treated for nasopharyngeal cancer and was found to have a lesion compatible with metastasis at the old PEG site 7 years later.

Keywords

Metastasis, nasopharyngeal cancer, percutaneous endoscopic gastrostomy

Nazofarenks Kanserine Bağlı İzole Perkütan Endoskopik Gastrostomi Bölgesi Malignitesi: Olgu Sunumu

Abstract

PEG (Perkütan Endoskopik Gastrostomi) işlemi, ağız yoluyla beslenme yeteneği bozulan baş ve boyun kanseri hastalarında kullanılan bir yöntemdir. Çok nadir olmakla birlikte, PEG bölgesindeki primer malign tümörle uyumlu hücrelerin implantasyonu nedeniyle metastaz meydana gelebilir. Vaka sunumumuzda, nazofarenks kanseri tedavisi gören ve eski PEG bölgesinde metastazla uyumlu bir lezyonun 7 yıl sonra görüldüğü bir hastayı sunmayı amaçladık.

Keywords

Metastas, nazofarinks kanseri, perkütan endoskopik gastrostomi

References

• Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr 2017;36(5):1187-1196.
• Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet 2019;394(10192):64-80.
• Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol 2014;20(24):7739-7751.
• Shah AB, Nagalli S. Nasopharyngeal Carcinoma. In: StatPearls. Treasure Island (FL): StatPearls Publishing; October 1, 2022.
• Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet 2016;387(10022):1012-1024.
• Vincenzi F, De Caro G, Gaiani F, et al. Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors. Acta Biomed 2018;89(8-S):117-121.
• Huang AT, Georgolios A, Espino S, Kaplan B, Neifeld J, Reiter ER. Percutaneous endoscopic gastrostomy site metastasis from head and neck squamous cell carcinoma: case series and literature review. J Otolaryngol Head Neck Surg 2013;42(1):20.
• Laccourreye O, Chabardes E, Mérite-Drancy A, et al. Implantation metastasis following percutaneous endoscopic gastrostomy. J Laryngol Otol 1993;107(10):946-949.
• Ellrichmann M, Sergeev P, Bethge J, et al. Prospective evaluation of malignant cell seeding after percutaneous endoscopic gastrostomy in patients with oropharyngeal/esophageal cancers. Endoscopy 2013;45(7):526-531.
• Tucker AT, Gourin CG, Ghegan MD, Porubsky ES, Martindale RG, Terris DJ. 'Push' versus 'pull' percutaneous endoscopic gastrostomy tube placement in patients with advanced head and neck cancer. Laryngoscope 2003;113(11):1898-1902.